67 year old female patient with complaints of life style limiting claudication symptoms in both legs, left more than right (Rutherford Grade II category 4) on medication (Cilostazol) and exercise program on presentation.
Past Medical History: Hypertension, Diabetes Mellitus Type II, Hyperlipidemia, PAD, CAD s/p PCI of LAD and RCA, Hepatitis B, Anemia of chronic disease
Medications: Atorvastatin 40mg PO daily, metoprolol XL 25 mg PO daily, HCTZ 12.5 mg PO daily, Aspirin 81mg PO daily, clopidogrel 75 mg PO daily, Lantus 15 units, Amlodipine 10mg PO daily, Cilostazol 100mg PO BID
Social History: Non Smoker, no alcohol or IVDA
Plan: Patient now planned for Recanalizaton of CTO, Atherectomy and PTA of long segment calcified left superficial femoral artery stenosis.
LEFT SFA CTO REVASCULARIZATION – August 2020
Case and Plan: 55 year-old-male with mutliple comorbidities, who presents with ongoing, bilateral lifestyle-limiting claudication now progressed to rest pain (L>R) who is status post R SFA CTO intervention and now planned for L SFA CTO intervention via femoral approach.
Transradial Approach for CFA Intervention Involving Fem-Fem Bypass Graft – July 2020
Case and Plan: 70 year-old male with a PMHx of HTN, HLD, asthma, NIDDM, CKD Stage III, HFpEF (55%), MGUS, CAD s/p 2vCABG and PAD s/p bilateral common iliac stent c/b left common iliac artery stent occlusion s/p R->L fem-fem bypass who is presenting with progressive claudication now present at rest (Rutherford 4). Lower extremity […]
Chronic total occlusion (CTO) of left popliteal artery – June 2020
Case and Plan: This is a 68 F with hypertension, diabetes, dyslipidemia and peripheral arterial disease who had prior interventions of the right lower extremity. She presented to the office with life style limiting claudication that has progressed to pain at rest despite optimal medical and exercise therapy. Non invasive studies showed severely reduced ABI […]
Management of CLI and ALI During the COVID-19 Pandemic – May 2020
Case and Plan: Live Discussion with Q&A on “Management of CLI and ALI During the COVID-19 Pandemic